Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

DHAIS plc : Statement re Delay in Publication of Financial Results

Posted on: 30 Nov 17

Delay in Publication of Financial Results

DHAIS plc ("DHAIS" or the "Company") announces that the audit process of its annual financial statements is still ongoing and therefore there will be a delay in the publication of its financial results for the year ended 30 June 2017.

The Company is currently seeking clarification of support from its main funder with a view to finalising the audit and announcing the financial results as soon as possible.

The Directors of the Issuer accept responsibility for this announcement.

Amin Kiddy
Director, DHAIS Plc
Tel:  +44 (0) 2920 666888

Jon Isaacs
NEX Exchange Corporate Advisor
Alfred Henry Corporate Finance Limited
Tel: +44 (0) 20 7251 3762

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DHAIS plc via GlobeNewswire

Last updated on: 01/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.